Sentrian

About Sentrian

Sentrian, which operated under the domain sentrian.com, was a healthcare technology firm positioned as a Remote Patient Intelligence company. The company was founded in 2012 with its headquarters in Aliso Viejo, California, and ceased operations in December 2018. The leadership team included co-founder and CEO Dean Sawyer, who had previous executive experience at Allscripts and Physicians Interactive. He was joined by a team that included Founder and Chief Medical Officer Dr. Jack Kreindler, Chief Medical Scientist Dr. Marty Kohn, and Chief Technology Officer Dr. Lance Myers. The idea for the company reportedly originated from a Singularity University Executive Program.

Sentrian's core business was focused on reducing preventable hospital admissions for patients with complex chronic diseases. Its business model revolved around providing a cloud-based remote patient monitoring and analytics platform to healthcare organizations, such as health insurance plans. The company aimed to help these at-risk organizations improve their shared savings performance by lowering hospitalization rates among their highest-risk patients. Revenue was presumably generated through subscriptions or service fees for access to their platform. The company was venture-backed, having raised capital in several rounds, including a $4 million seed round in 2014.

The company's product was the Sentrian Remote Patient Intelligence (RPI) platform. This system was designed to analyze data from remote biosensors and wearables to detect early signs of health deterioration in patients before their condition became acute. The platform utilized machine learning to create personalized patient baselines and continuously enhance its predictive models. A key feature was its device-agnostic approach, allowing clinicians to select the most appropriate and least intrusive biosensors for each patient. The platform was designed to integrate with existing healthcare information systems like electronic medical records, and it received FDA clearance for commercial marketing in the U.S. in 2015.